CN Patent

CN116669726A — 对外核苷酸焦磷酸酶-磷酸二酯酶具有抑制活性的新颖的萘啶酮衍生物及其用途

Assigned to Dixinuo Biotechnology Co ltd · Expires 2023-08-29 · 3y expired

What this patent protects

本发明涉及新颖的萘啶酮衍生化合物、其药学上可接受的盐、其水合物或其立体异构体，它们各自与用于抑制ENPP1的化合物、用于抑制ENPP1的组合物和用于抑制ENPP1的方法有关。

USPTO Abstract

本发明涉及新颖的萘啶酮衍生化合物、其药学上可接受的盐、其水合物或其立体异构体，它们各自与用于抑制ENPP1的化合物、用于抑制ENPP1的组合物和用于抑制ENPP1的方法有关。

Drugs covered by this patent

Patent Metadata

Patent number
CN116669726A
Jurisdiction
CN
Classification
—
Expires
2023-08-29
Drug substance claim
No
Drug product claim
No
Assignee
Dixinuo Biotechnology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.